SEC Form 4 · accession 0001179110-16-023212
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Bishop
Officer — Senior VP, Pharmaceutical Scie
Period of report
Apr 18, 2016
Accepted (ET)
Apr 19, 2016 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 18, 2016 | F | 6,206 | $9.69 | D | 160,880 | D | |
| Common StockF3 | Apr 19, 2016 | S | 2,843 | $9.57 | D | 158,037 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares of restricted common stock returned to the company to meet minimum tax liability requirements, pursuant to the related exercise and restricted stock agreement, as amended, between Mr. Bishop and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.
- F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2015.
- F3This transaction was executed in multiple trades at prices ranging from $9.45 to $9.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.